Delivery Order SPE2DB22D1106-SPE2DB25FEZS1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,680.22 to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 5 mg tablets (100 count) on August 8, 2025, with an ultimate completion date of August 11, 2025. This delivery order is structured as a firm fixed-price contract with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $1,282.64 to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 10 mg tablets in unit dose packaging (100 count). This contract was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, and represents a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $5,133.56 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of 500 tablets of Cetirizine HCL 10 mg. This competitively awarded, firm fixed-price contract is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical delivery will be performed at the contractor's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,528.93 to AmerisourceBergen Drug Corp for 500 tablets of Cetirizine HCL 10 mg, with an ultimate completion date of July 24, 2025. This non-set-aside, firm fixed-price delivery order represents a competitive award to supply pharmaceutical products supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cetirizine Hydrochloride 5 mg tablets. The contract has a ceiling value of $16,241.24 and is a firm fixed price award without a set-aside designation, indicating open competition. The ultimate completion date is June 9, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,448.16 fixed-price delivery order is for the procurement of 4,563,703,529 units of cetirizine 5mg tablets. The contract has an ultimate completion date of March 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,197.91 firm-fixed-price delivery order is for the supply of 4,562,549,817 units of Cetirizine HCL 5 mg tablets. The contract has an ultimate completion date of October 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Cetirizine HCL 5 mg tablets. The contract has a firm fixed price of $1,992.80 and an ultimate completion date of May 16, 2025. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not set aside. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4,564,324,108 units of Cetirizine HCL 5 mg tablets in 100-count bottles. The contract has a total ceiling value of $3,115.11 and is a firm fixed price delivery order contract. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,559,880 units of Cetirizine HCL 10 mg tablets. The $8,582.74 firm fixed price contract has a completion date of February 9, 2023 and was awarded on February 8, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEZS1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,119.60 to AmerisourceBergen Drug Corp for Cetirizine HCL 10 mg tablets in unit dose packaging containing 100 tablets. This is a firm fixed price delivery order with no set-aside designation, competitively awarded and due for completion by July 28, 2025. The order will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The parent IDC encompasses a broad portfolio of pharmaceutical products, vaccines, and medical supplies across multiple therapeutic domains, enabling DLA to fulfill medical supply requirements for defense and related federal healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 7/25/25 |